# Artelo Biosciences announces 1-for-9 reverse stock split — retained record

> Retained news record from news:seeking-alpha.

Canonical: https://highsignal.app/data/records/f6bd01da976c389a

[← sources](https://highsignal.app/data)


source: [news](https://highsignal.app/data/news) (news:seeking-alpha)  published 2026-08-27 12:55 ingested 2026-08-27 13:04

[original source ↗](https://seekingalpha.com/news/4637463-artelo-biosciences-announces-1-forminus-9-reverse-stock-split?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news)

## retained text



```
- Artelo Biosciences (NASDAQ: ARTL) announced on Thursday it will effect a 1-for-9 reverse stock split of its common stock, with trading to begin Aug. 31.
- No fractional shares will be issued, with holders receiving one whole share instead.
- The company said the reverse split is intended to increase its share price and improve marketability and liquidity.
- Pursuant to the transaction, the company expects approximately 547,774 shares of common stock to be outstanding.
- Outstanding warrants and other derivatives will automatically adjust to reflect the reverse split.
- Share -0.92%
```



document fetched 2026-08-27 13:04 · canonical https://seekingalpha.com/news/4637463-artelo-biosciences-announces-1-forminus-9-reverse-stock-split?feed_item_type=news